Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The APL Channel

Explore the latest updates and expert interviews

Welcome to The Acute Promyelocytic Leukemia (APL) Channel

VJHemOnc covers exciting and topical research directly from the experts at major international congresses so that you can stay informed.

Many patients with acute promyelocytic leukemia are cured with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). However, ongoing research is looking into improving the early identification and treatment of patients, developing strategies for high-risk patients, and examining maintenance therapies in low-risk patients. For more information, watch our video interviews with leading experts.